Fred Cohen, assistant professor of medicine and neurology at the Icahn School of Medicine at Mount Sinai in New York, told ...

Since its founding in 2018, Olfax has secured an increasing level of funding through grants and awards, boosted in 2022 with awards totaling $35,000 as a regional and top-three statewide winner in the ...

But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is. Fighting for ...

For decades, the standard treatment for these potentially life-threatening ... If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic ...

Addressing a critical need in lung health The findings underscore a critical gap in research and treatment for lung conditions. Dr. Samantha Walker, Director of Research and Innovation at Asthma + ...

The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a lung condition called chronic obstructive pulmonary disease (COPD). The medication, ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and lead to the first leap in treatment for 50 years, researchers have said.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low ...

Once in a while, we all get a headache. And 70% of the time, it’s caused by stress and tension. Most people will pop a painkiller and hope the pain goes away quickly. But for migraine sufferers ...

A new drug could be a lifesaver. Photo by Quaid Lagan on UnSplash. Researchers say they have discovered the first new treatment for asthma attacks in 50 years. The treatment is an injection that calms ...